BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 9156559)

  • 1. Abnormal cholinesterase activity: understanding and interpretation.
    Jokanović M; Maksimović M
    Eur J Clin Chem Clin Biochem; 1997 Jan; 35(1):11-6. PubMed ID: 9156559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prevention, diagnosis and treatment of poisoning with pesticides, derivatives of organophosphorus compounds and carbamates].
    Kontek M; Paradowski S
    Pol Tyg Lek; 1974 Feb; 29(8):333-5. PubMed ID: 4592843
    [No Abstract]   [Full Text] [Related]  

  • 3. Kinetic analysis of the protection afforded by reversible inhibitors against irreversible inhibition of acetylcholinesterase by highly toxic organophosphorus compounds.
    Eckert S; Eyer P; Mückter H; Worek F
    Biochem Pharmacol; 2006 Jul; 72(3):344-57. PubMed ID: 16780806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potency of five structurally different acetylcholinesterase reactivators to reactivate human brain cholinesterases inhibited by cyclosarin.
    Kuca K; Cabal J; Jun D; Hrabinova M
    Clin Toxicol (Phila); 2007; 45(5):512-5. PubMed ID: 17503257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biochemical characteristics of aminostigmine--a new anticholinesterase agent].
    Prozorovskiĭ VB; Rozengart VI; Ardab'eva TV; Kugusheva LI; Suslova IM
    Biokhimiia; 1996 Apr; 61(4):690-6. PubMed ID: 8724787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinesterases from the common oyster (Crassostrea gigas). Evidence for the presence of a soluble acetylcholinesterase insensitive to organophosphate and carbamate inhibitors.
    Bocquene G; Roig A; Fournier D
    FEBS Lett; 1997 May; 407(3):261-6. PubMed ID: 9175864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and optimization of reactivation techniques for carbamate-inhibited brain and plasma cholinesterases in birds and mammals.
    Hunt KA; Hooper MJ
    Anal Biochem; 1993 Aug; 212(2):335-43. PubMed ID: 8214574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A tryptophan in the bottleneck of the catalytic gorge of an invertebrate acetylcholinesterase confers relative resistance to carbamate and organophosphate inhibitors.
    Patel R; Sanders R; Brown L; Baker S; Tsigelny I; Pezzementi L
    Cell Biochem Biophys; 2006; 46(3):253-64. PubMed ID: 17272851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning.
    Jokanović M; Stojiljković MP
    Eur J Pharmacol; 2006 Dec; 553(1-3):10-7. PubMed ID: 17109842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible inhibition of acetylcholinesterase by carbamates or huperzine A increases residual activity of the enzyme upon soman challenge.
    Eckert S; Eyer P; Worek F
    Toxicology; 2007 Apr; 233(1-3):180-6. PubMed ID: 17097792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of cholinesterase reactivators on brain acetylcholinesterase of animals poisoned by isopropyl methylphosphonofluoridate.
    Bajgar J
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove; 1974; 17(3):165-98. PubMed ID: 4534272
    [No Abstract]   [Full Text] [Related]  

  • 12. In vitro oxime-assisted reactivation of paraoxon-inhibited human acetylcholinesterase and butyrylcholinesterase.
    Musilova L; Kuca K; Jung YS; Jun D
    Clin Toxicol (Phila); 2009 Jul; 47(6):545-50. PubMed ID: 19586353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic bioscavengers against organophosphorus agents: mechanistic issues of self-reactivating cholinesterases.
    Lushchekina S; Masson P
    Toxicology; 2018 Nov; 409():91-102. PubMed ID: 30056174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phosphorus atom availability and mechanism enzyme inhibiting effect of organophosphorous inhibitors of cholinesterases of various origin. Results of conformational and correlational analysis].
    Rozengart EV; Shestakova NN; Prokator SO; Basova NE
    Zh Evol Biokhim Fiziol; 1999; 35(1):36-9. PubMed ID: 10399821
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of the decarbamylation process of cholinesterase during assay of enzyme activity.
    Rotenberg M; Almog S
    Clin Chim Acta; 1995 Sep; 240(2):107-16. PubMed ID: 8548921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical treatment of acute poisoning with organophosphorus and carbamate pesticides.
    Jokanović M
    Toxicol Lett; 2009 Oct; 190(2):107-15. PubMed ID: 19651196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cholinesterase. Abbreviation and sample cases in Baghdad.
    Raafat HR
    Bull Endem Dis (Baghdad); 1978 Nov; 19(1-4):39-43. PubMed ID: 757129
    [No Abstract]   [Full Text] [Related]  

  • 19. [The action of cholinesterase reactivators on the body not related to the recovery of the activity of phosphorylated acetylcholinesterase].
    Shorokhov IuA; Zatsepin EP; Androsov NS
    Eksp Klin Farmakol; 1993; 56(4):62-6. PubMed ID: 8106061
    [No Abstract]   [Full Text] [Related]  

  • 20. Reactivation and aging kinetics of human acetylcholinesterase inhibited by organophosphonylcholines.
    Worek F; Thiermann H; Szinicz L
    Arch Toxicol; 2004 Apr; 78(4):212-7. PubMed ID: 14647978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.